Woosley RL - Search Results

1

Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.

Murray KT, Reilly C, Koshakji RP, Roden DM, Lineberry MD, Wood AJ, Siddoway LA, Barbey JT, Woosley RL. Murray KT, et al. Among authors: woosley rl. J Clin Invest. 1990 Mar;85(3):836-42. doi: 10.1172/JCI114510. J Clin Invest. 1990. PMID: 2155929 Free PMC article.

2

Antiarrhythmic activity, electrocardiographic effects and pharmacokinetics of the encainide metabolites O-desmethyl encainide and 3-methoxy-O-desmethyl encainide in man.

Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM. Barbey JT, et al. Among authors: woosley rl. Circulation. 1988 Feb;77(2):380-91. doi: 10.1161/01.cir.77.2.380. Circulation. 1988. PMID: 3123092 Clinical Trial.

3

Tocainide plus quinidine for treatment of ventricular arrhythmias.

Barbey JT, Thompson KA, Echt DS, Woosley RL, Roden DM. Barbey JT, et al. Among authors: woosley rl. Am J Cardiol. 1988 Mar 1;61(8):570-3. doi: 10.1016/0002-9149(88)90766-7. Am J Cardiol. 1988. PMID: 3125737

4

The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmias.

Wang T, Siddoway LA, Thompson KA, Conard GJ, Bergstrand RH, Kvam D, Roden DM, Woosley RL. Wang T, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1988 May;43(5):499-508. doi: 10.1038/clpt.1988.65. Clin Pharmacol Ther. 1988. PMID: 3130211

5

Prospective pharmacokinetically based development of effective infusion regimens for ACC-9358, a new antiarrhythmic drug.

Pavlou HN, Funck-Brentano C, Lineberry MD, Woosley RL, Roden DM. Pavlou HN, et al. Among authors: woosley rl. Clin Pharmacol Ther. 1991 Mar;49(3):314-21. doi: 10.1038/clpt.1991.35. Clin Pharmacol Ther. 1991. PMID: 2007325 Clinical Trial.

6

A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.

Funck-Brentano C, Silberstein DJ, Roden DM, Wood AJ, Woosley RL. Funck-Brentano C, et al. Among authors: woosley rl. Br J Clin Pharmacol. 1990 Aug;30(2):195-202. doi: 10.1111/j.1365-2125.1990.tb03765.x. Br J Clin Pharmacol. 1990. PMID: 2169833 Free PMC article. Clinical Trial.

7

The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenone.

Lee JT, Kroemer HK, Silberstein DJ, Funck-Brentano C, Lineberry MD, Wood AJ, Roden DM, Woosley RL. Lee JT, et al. Among authors: woosley rl. N Engl J Med. 1990 Jun 21;322(25):1764-8. doi: 10.1056/NEJM199006213222502. N Engl J Med. 1990. PMID: 1971708 Free article. Clinical Trial.

8

Clinical pharmacokinetics of encainide.

Roden DM, Woosley RL. Roden DM, et al. Among authors: woosley rl. Clin Pharmacokinet. 1988 Mar;14(3):141-7. doi: 10.2165/00003088-198814030-00002. Clin Pharmacokinet. 1988. PMID: 3131058 Review.

9

Potent electrophysiologic effects of the major metabolites of propafenone in canine Purkinje fibers.

Thompson KA, Iansmith DH, Siddoway LA, Woosley RL, Roden DM. Thompson KA, et al. Among authors: woosley rl. J Pharmacol Exp Ther. 1988 Mar;244(3):950-5. J Pharmacol Exp Ther. 1988. PMID: 3252042

10

Electrophysiologic effects of intravenous and oral sotalol for sustained ventricular tachycardia secondary to coronary artery disease.

Kopelman HA, Woosley RL, Lee JT, Roden DM, Echt DS. Kopelman HA, et al. Among authors: woosley rl. Am J Cardiol. 1988 May 1;61(13):1006-11. doi: 10.1016/0002-9149(88)90116-6. Am J Cardiol. 1988. PMID: 3284316 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

263 results

Search Page

Filters